Bladder Cancer Breakthrough (EU-wide, incl. Liechtenstein): The European Commission approved Merck/MSD’s Keytruda (pembrolizumab) plus Padcev (enfortumab vedotin) as a perioperative treatment for adults with resectable muscle-invasive bladder cancer who can’t receive cisplatin—based on KEYNOTE-905/EV-303 results showing major gains in event-free survival, overall survival, and pathologic complete response. Breast Cancer Option (EU-wide, incl. Liechtenstein): Gilead’s Trodelvy (sacituzumab govitecan) won first-line approval in metastatic triple-negative breast cancer for patients not eligible for PD-1/PD-L1 therapy. Crypto Regulation Boost (Liechtenstein): Bitcoin Suisse secured a MiCAR CASP license from Liechtenstein’s FMA, giving it a regulated base to expand services across selected EEA markets. Stablecoin Infrastructure (EEA-wide): OpenPayd also obtained MiCA authorization to offer fiat-to-stablecoin on/off-ramping, custody, and stablecoin transfers across the EEA. Digital Trust & Onboarding: Shufti and Evrotrust partnered to combine identity verification with Qualified Electronic Signatures in one onboarding flow across all 27 EU states. Public Safety (Switzerland): Switzerland expanded its heatwave warning to level 4 across large regions, with no relief expected until Monday. Space Education (Liechtenstein-linked regionally): A UN-published children’s space book from the Philippines was launched at COPUOS, highlighting peaceful space use and space diplomacy.